A new generation of clinical endpoint trials in HIV

被引：0
|
作者：
Neaton, JD [1 ]
Babiker, AGA [1 ]
机构：
[1] Univ Minnesota, Minneapolis, MN 55455 USA
来源：
CONTROLLED CLINICAL TRIALS | 2003年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
16
引用
收藏
页码：51S / 51S
页数：1
相关论文
共 50 条
  • [31] Quality of life as an endpoint for clinical trials of prostate cancer
    Tannock, I
    ANNALS OF ONCOLOGY, 1998, 9 : 54 - 55
  • [32] A Day 14 Endpoint for Acute GVHD Clinical Trials
    Spyrou, Nikolaos
    Akahoshi, Yu
    Kowalyk, Steven
    Morales, George
    Beheshti, Rahnuma
    Aguayo-Hiraldo, Paibel
    Al Malki, Monzr M.
    Ayuk, Francis
    Bader, Peter
    Baez, Janna
    Capellini, Alexandra
    Choe, Hannah
    Defilipp, Zachariah
    Eder, Matthias
    Eng, Gilbert
    Etra, Aaron
    Gleich, Sigrun
    Grupp, Stephan A.
    Hexner, Elizabeth
    Hoepting, Matthias
    Hogan, William J.
    Kasikis, Stelios
    Katsivelos, Nikolaos
    Khan, Alina
    Kitko, Carrie L.
    Kraus, Sabrina
    Kwon, Deukwoo
    Merli, Pietro
    Portelli, Joseph
    Qayed, Muna
    Reshef, Ran
    Schechter, Tal
    Vasova, Ingrid
    Woefl, Matthias
    Wudhikarn, Kitsada
    Young, Rachel
    Holler, Ernst
    Chen, Yi-Bin
    Nakamura, Ryotaro
    Levine, John E.
    Ferrara, James L. M.
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (04): : 421 - 432
  • [33] Kidney function assessment and endpoint ascertainment in clinical trials
    Khan, Muhammad Shahzeb
    Bakris, George L.
    Packer, Milton
    Shahid, Izza
    Anker, Stefan D.
    Fonarow, Gregg C.
    Wanner, Christoph
    Weir, Matthew R.
    Zannad, Faiez
    Butler, Javed
    EUROPEAN HEART JOURNAL, 2022, 43 (14) : 1379 - 1400
  • [34] 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials
    Hicks, Karen A.
    Mahaffey, Kenneth W.
    Mehran, Roxana
    Nissen, Steven E.
    Wiviott, Stephen D.
    Dunn, Billy
    Solomon, Scott D.
    Marler, John R.
    Teerlink, John R.
    Farb, Andrew
    Morrow, David A.
    Targum, Shari L.
    Sila, Cathy A.
    Hai, Mary T. Thanh
    Jaff, Michael R.
    Joffe, Hylton V.
    Cutlip, Donald E.
    Desai, Akshay S.
    Lewis, Eldrin F.
    Gibson, C. Michael
    Landray, Martin J.
    Lincoff, A. Michael
    White, Christopher J.
    Brooks, Steven S.
    Rosenfield, Kenneth
    Domanski, Michael J.
    Lansky, Alexandra J.
    McMurray, John J. V.
    Tcheng, James E.
    Steinhubl, Steven R.
    Burton, Paul
    Mauri, Laura
    O'Connor, Christopher M.
    Pfeffer, Marc A.
    Hung, H. M. James
    Stockbridge, Norman L.
    Chaitman, Bernard R.
    Temple, Robert J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (09) : 1021 - 1034
  • [35] Are there alternatives to mortality as an endpoint in clinical trials of atrial fibrillation?
    Wyse, DG
    HEART RHYTHM, 2004, 1 (02) : B41 - B44
  • [36] A Day 14 Endpoint for Acute Gvhd Clinical Trials
    Spyrou, Nikolaos
    Akahoshi, Yu
    Kowalyk, Steven
    Morales, George
    Beheshti, Rahnuma
    Aguayo-Hiraldo, Paibel
    Al Malki, Monzr
    Ayuk, Francis Ayuketang
    Bader, Peter
    Baez, Janna
    Capellini, Alexandra
    Choe, Hannah
    Defilipp, Zachariah
    Eder, Matthias
    Eng, Gilbert
    Etra, Aaron
    Gleich, Sigrun
    Grupp, Stephan
    Hexner, Elizabeth
    Hoepting, Matthias
    Hogan, William J.
    Kasikis, Stelios
    Katsivelos, Nikolaos
    Kitko, Carrie L.
    Kraus, Sabrina
    Kwon, Deukwoo
    Merli, Pietro
    Portelli, Joseph
    Qayed, Muna
    Reshef, Ran
    Schechter-Finkelstein, Tal
    Vasova, Ingrid
    Woelfl, Matthias
    Wudhikarn, Kitsada
    Young, Rachel
    Holler, Ernst
    Chen, Yi-Bin
    Nakamura, Ryotaro
    Levine, John
    Ferrara, James L. M.
    BLOOD, 2023, 142
  • [37] When do we need clinical endpoint adjudication in clinical trials?
    Held, Claes
    UPSALA JOURNAL OF MEDICAL SCIENCES, 2019, 124 (01) : 42 - 45
  • [38] Patient Diaries As a Clinical Endpoint in Parkinson's Disease Clinical Trials
    Papapetropoulos, Spyridon
    CNS NEUROSCIENCE & THERAPEUTICS, 2012, 18 (05) : 380 - 387
  • [39] Neuroimaging as a Selection Tool and Endpoint in Clinical and Pre-clinical Trials
    Muir, Keith W.
    Macrae, I. Mhairi
    TRANSLATIONAL STROKE RESEARCH, 2016, 7 (05) : 368 - 377
  • [40] Neuroimaging as a Selection Tool and Endpoint in Clinical and Pre-clinical Trials
    Keith W. Muir
    I. Mhairi Macrae
    Translational Stroke Research, 2016, 7 : 368 - 377
12345